Cuorips Inc.

¥6,050As of Sun 8 Nov 2026, 12:00 UTC
TSE:4894Healthcare
Country Japan
PE (Fwd) •••
TSR 3Y CAGR 49.19%
Div yield —
ROE (23.28%)
Biotechnology
Beta (5Y) 0.78
PE TTM —
TSR TTM (5.62%)
Mkt cap ¥53.73B
ROIC (15.41%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6,374
5.36%
75.31%
Hold 7|10|9|8|2
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
76.58
82.74
87.01
89.67
6.08%
9.35%
13.67%
14.68%
Revenue¥B
6.578
6.653
6.735
6.877
0.15%
2.74%
3.63%
1.42%
Peers (US$341.1M)
Cap (US$)
PE
392.5M
—
240.5M
10.86x
340.9M
6.177x
Capital
TTM
5Y
10Y
Leveragex
0.149
(0.668)
(0.672)
EBIT/Intx
0.518
0.276
0.248
Own earn%
24.65
205.00
157.73
Sh yield%
48.74
59.14
59.33
Owners
Insiders/Inst%
5.14
75.44
Short interest%
4.42
SBC / revenue%
4.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
17–25
$1 testx
—
Incr. ROIC%
22